Valuation : Ind-Swift Laboratories Limited

Market Cap 11.4B 120M 104M 97.44M 88.77M 167M 168M 1.15B 448M 5.8B 451M 441M 19.22B P/E 2024
1.41x
P/E 2025 2.38x
Enterprise Value 7.13B 75.14M 64.81M 60.97M 55.54M 104M 105M 721M 281M 3.63B 282M 276M 12.03B EV / Sales 2024
0.14x
EV / Sales 2025 0.12x
Free-Float
36.27%
Yield 2024 *
-
Yield 2025 -
1 day+0.90%
1 week+12.49%
Current month+0.90%
1 month+64.15%
3 months+142.03%
6 months+153.32%
Current year+317.64%
1 week 325.98
Extreme 325.98
389.5
1 month 222.2
Extreme 222.2
389.5
Current year 87.25
Extreme 87.25
389.5
1 year 87.15
Extreme 87.15
389.5
3 years 68.72
Extreme 68.72
389.5
5 years 52.65
Extreme 52.65
389.5
10 years 15
Extreme 15
389.5
Manager TitleAgeSince
Chief Executive Officer 74 1995-01-03
Chief Executive Officer 44 2011-06-14
Director of Finance/CFO - 2018-09-28
Director TitleAgeSince
Director/Board Member 44 -
Chairman 74 -
Director/Board Member 35 2010-03-22
Date Insider Type Main position Quantity % Market Cap. Importance
9/12/24 Sell

Chief Financial Officer

30,000 0.0508%
Change 5-day change 1-year change 3-year change Capi.($)
+0.90%+12.49%+283.25%+250.45% 333M
-2.81%+0.99%+20.98%+73.53% 50.05B
+1.14%+1.47%+59.54%+123.40% 40.29B
+0.56%+5.80%+19.04%+86.59% 12.17B
+0.98%-1.04%-10.47%+13.15% 11.96B
+0.19%+0.97%+29.35%+148.80% 9.25B
-0.15%-1.87%+25.21%+46.24% 7.62B
-0.39%+3.33%+28.41%+222.15% 7.36B
+1.43%+1.70%+50.00%-9.99% 7.21B
-0.13%+0.79%-36.70%+15.26% 5.26B
Average +0.17%+2.10%+46.86%+96.96% 15.15B
Weighted average by Cap. -0.45%+1.77%+29.63%+87.91%

Financials

2024 2025
Net sales 12.97B 137M 118M 111M 101M 190M 191M 1.31B 510M 6.6B 513M 502M 21.88B 5.62B 59.19M 51.05M 48.02M 43.75M 82.27M 82.72M 568M 221M 2.86B 222M 217M 9.47B
Net income 4.21B 44.36M 38.26M 35.99M 32.79M 61.66M 61.99M 425M 166M 2.14B 167M 163M 7.1B 2.5B 26.39M 22.77M 21.41M 19.51M 36.69M 36.89M 253M 98.54M 1.27B 99.09M 96.94M 4.22B
Net Debt -4.15B -43.76M -37.75M -35.51M -32.35M -60.83M -61.16M -420M -163M -2.11B -164M -161M -7B -4.27B -44.94M -38.77M -36.47M -33.22M -62.48M -62.81M -431M -168M -2.17B -169M -165M -7.19B
Logo Ind-Swift Laboratories Limited
Ind-Swift Laboratories Limited is an India-based company, which is engaged in the business of manufacturing active pharmaceutical ingredients (APIs), intermediates and formulations. The Company operates in the Pharmaceutical Business segment. It also focuses on manufacturing formulations. The Company’s products include APIs and Impurities. Its APIs therapeutic category includes Macrolide Antibiotic, Cardiovascular, Antihistaminic, Antidiabetic, Antipsyhotic, Bone Resorption Inhibitor, and Aromatase Inhibitor. Its products include Clarithromycin, Clarithromycin Coated Granules, Clarithromycin Citrate, Atorvastatin Calcium Crystalline, Atorvastatin Calcium Amorphous, Clopidogrel HCl, Ezetimibe, Ivabradine Oxalate, Ranolazine, Aripiprazole, Risedronate Sodium, Ropinirole HCl, Cinacalcet HCl, Letrozole, and Anastrozole. Its products under development include Sitagliptin Phosphate, Mirabegron, Bempedoic Acid, Lasmiditan, and Eltrombopag Olamine.
Employees
1,246
Date Price Change Volume
26-09-01 368.15 +0.90% 1,383,073
26-08-31 ₹364.87 +0.54% 667,877
26-08-28 ₹362.92 +1.36% 527,926
26-08-27 ₹358.04 -2.57% 694,257
26-08-26 ₹367.48 +13.29% 7,368,383
  1. Stock Market
  2. Stocks
  3. INDSWFTLAB Stock